[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Hepatocyte Growth Factor Market Report 2017

December 2017 | 98 pages | ID: UB7B15692F4EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Hepatocyte Growth Factor market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Hepatocyte Growth Factor in these regions, from 2012 to 2022 (forecast).
United States Hepatocyte Growth Factor market competition by top manufacturers/players, with Hepatocyte Growth Factor sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Amgen Inc.
  • AnGes MG, Inc.
  • Kringle Pharma, Inc.
  • M3 Biotechnology, Inc.
  • Minerva Biotechnologies Corporation
  • Molecular Partners AG
  • ViroMed Co., Ltd.
  • Yooyoung Pharmaceutical Co., Ltd.
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Beperminogene Perplasmid
  • FS-101
  • MP-0250
  • NDX-1017
  • NK-4
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Coronary Arterial Disease
  • Arteriosclerosis
  • Colorectal Cancer
  • Dementia
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Hepatocyte Growth Factor Market Report 2017

1 HEPATOCYTE GROWTH FACTOR OVERVIEW

1.1 Product Overview and Scope of Hepatocyte Growth Factor
1.2 Classification of Hepatocyte Growth Factor by Product Category
  1.2.1 United States Hepatocyte Growth Factor Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Hepatocyte Growth Factor Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Beperminogene Perplasmid
  1.2.4 FS-101
  1.2.5 MP-0250
  1.2.6 NDX-1017
  1.2.7 NK-4
  1.2.8 Others
1.3 United States Hepatocyte Growth Factor Market by Application/End Users
  1.3.1 United States Hepatocyte Growth Factor Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Coronary Arterial Disease
  1.3.3 Arteriosclerosis
  1.3.4 Colorectal Cancer
  1.3.5 Dementia
  1.3.6 Others
1.4 United States Hepatocyte Growth Factor Market by Region
  1.4.1 United States Hepatocyte Growth Factor Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Hepatocyte Growth Factor Status and Prospect (2012-2022)
  1.4.3 Southwest Hepatocyte Growth Factor Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Hepatocyte Growth Factor Status and Prospect (2012-2022)
  1.4.5 New England Hepatocyte Growth Factor Status and Prospect (2012-2022)
  1.4.6 The South Hepatocyte Growth Factor Status and Prospect (2012-2022)
  1.4.7 The Midwest Hepatocyte Growth Factor Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Hepatocyte Growth Factor (2012-2022)
  1.5.1 United States Hepatocyte Growth Factor Sales and Growth Rate (2012-2022)
  1.5.2 United States Hepatocyte Growth Factor Revenue and Growth Rate (2012-2022)

2 UNITED STATES HEPATOCYTE GROWTH FACTOR MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Hepatocyte Growth Factor Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Hepatocyte Growth Factor Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Hepatocyte Growth Factor Average Price by Players/Suppliers (2012-2017)
2.4 United States Hepatocyte Growth Factor Market Competitive Situation and Trends
  2.4.1 United States Hepatocyte Growth Factor Market Concentration Rate
  2.4.2 United States Hepatocyte Growth Factor Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Hepatocyte Growth Factor Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES HEPATOCYTE GROWTH FACTOR SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Hepatocyte Growth Factor Sales and Market Share by Region (2012-2017)
3.2 United States Hepatocyte Growth Factor Revenue and Market Share by Region (2012-2017)
3.3 United States Hepatocyte Growth Factor Price by Region (2012-2017)

4 UNITED STATES HEPATOCYTE GROWTH FACTOR SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Hepatocyte Growth Factor Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Hepatocyte Growth Factor Revenue and Market Share by Type (2012-2017)
4.3 United States Hepatocyte Growth Factor Price by Type (2012-2017)
4.4 United States Hepatocyte Growth Factor Sales Growth Rate by Type (2012-2017)

5 UNITED STATES HEPATOCYTE GROWTH FACTOR SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Hepatocyte Growth Factor Sales and Market Share by Application (2012-2017)
5.2 United States Hepatocyte Growth Factor Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES HEPATOCYTE GROWTH FACTOR PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Amgen Inc.
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Hepatocyte Growth Factor Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Amgen Inc. Hepatocyte Growth Factor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 AnGes MG, Inc.
  6.2.2 Hepatocyte Growth Factor Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 AnGes MG, Inc. Hepatocyte Growth Factor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Kringle Pharma, Inc.
  6.3.2 Hepatocyte Growth Factor Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Kringle Pharma, Inc. Hepatocyte Growth Factor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 M3 Biotechnology, Inc.
  6.4.2 Hepatocyte Growth Factor Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 M3 Biotechnology, Inc. Hepatocyte Growth Factor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Minerva Biotechnologies Corporation
  6.5.2 Hepatocyte Growth Factor Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Minerva Biotechnologies Corporation Hepatocyte Growth Factor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Molecular Partners AG
  6.6.2 Hepatocyte Growth Factor Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Molecular Partners AG Hepatocyte Growth Factor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 ViroMed Co., Ltd.
  6.7.2 Hepatocyte Growth Factor Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 ViroMed Co., Ltd. Hepatocyte Growth Factor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Yooyoung Pharmaceutical Co., Ltd.
  6.8.2 Hepatocyte Growth Factor Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Yooyoung Pharmaceutical Co., Ltd. Hepatocyte Growth Factor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview

7 HEPATOCYTE GROWTH FACTOR MANUFACTURING COST ANALYSIS

7.1 Hepatocyte Growth Factor Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Hepatocyte Growth Factor

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Hepatocyte Growth Factor Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Hepatocyte Growth Factor Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES HEPATOCYTE GROWTH FACTOR MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Hepatocyte Growth Factor Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Hepatocyte Growth Factor Sales Volume Forecast by Type (2017-2022)
11.3 United States Hepatocyte Growth Factor Sales Volume Forecast by Application (2017-2022)
11.4 United States Hepatocyte Growth Factor Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Hepatocyte Growth Factor
Figure United States Hepatocyte Growth Factor Market Size (K Pcs) by Type (2012-2022)
Figure United States Hepatocyte Growth Factor Sales Volume Market Share by Type (Product Category) in 2016
Figure Beperminogene Perplasmid Product Picture
Figure FS-101 Product Picture
Figure MP-0250 Product Picture
Figure NDX-1017 Product Picture
Figure NK-4 Product Picture
Figure Others Product Picture
Figure United States Hepatocyte Growth Factor Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Hepatocyte Growth Factor by Application in 2016
Figure Coronary Arterial Disease Examples
Table Key Downstream Customer in Coronary Arterial Disease
Figure Arteriosclerosis Examples
Table Key Downstream Customer in Arteriosclerosis
Figure Colorectal Cancer Examples
Table Key Downstream Customer in Colorectal Cancer
Figure Dementia Examples
Table Key Downstream Customer in Dementia
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Hepatocyte Growth Factor Market Size (Million USD) by Region (2012-2022)
Figure The West Hepatocyte Growth Factor Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Hepatocyte Growth Factor Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Hepatocyte Growth Factor Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Hepatocyte Growth Factor Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Hepatocyte Growth Factor Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Hepatocyte Growth Factor Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Hepatocyte Growth Factor Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Hepatocyte Growth Factor Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Hepatocyte Growth Factor Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Hepatocyte Growth Factor Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Hepatocyte Growth Factor Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Hepatocyte Growth Factor Sales Share by Players/Suppliers
Figure 2017 United States Hepatocyte Growth Factor Sales Share by Players/Suppliers
Figure United States Hepatocyte Growth Factor Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Hepatocyte Growth Factor Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Hepatocyte Growth Factor Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Hepatocyte Growth Factor Revenue Share by Players/Suppliers
Figure 2017 United States Hepatocyte Growth Factor Revenue Share by Players/Suppliers
Table United States Market Hepatocyte Growth Factor Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Hepatocyte Growth Factor Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Hepatocyte Growth Factor Market Share of Top 3 Players/Suppliers
Figure United States Hepatocyte Growth Factor Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Hepatocyte Growth Factor Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Hepatocyte Growth Factor Product Category
Table United States Hepatocyte Growth Factor Sales (K Pcs) by Region (2012-2017)
Table United States Hepatocyte Growth Factor Sales Share by Region (2012-2017)
Figure United States Hepatocyte Growth Factor Sales Share by Region (2012-2017)
Figure United States Hepatocyte Growth Factor Sales Market Share by Region in 2016
Table United States Hepatocyte Growth Factor Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Hepatocyte Growth Factor Revenue Share by Region (2012-2017)
Figure United States Hepatocyte Growth Factor Revenue Market Share by Region (2012-2017)
Figure United States Hepatocyte Growth Factor Revenue Market Share by Region in 2016
Table United States Hepatocyte Growth Factor Price (USD/Pcs) by Region (2012-2017)
Table United States Hepatocyte Growth Factor Sales (K Pcs) by Type (2012-2017)
Table United States Hepatocyte Growth Factor Sales Share by Type (2012-2017)
Figure United States Hepatocyte Growth Factor Sales Share by Type (2012-2017)
Figure United States Hepatocyte Growth Factor Sales Market Share by Type in 2016
Table United States Hepatocyte Growth Factor Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Hepatocyte Growth Factor Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Hepatocyte Growth Factor by Type (2012-2017)
Figure Revenue Market Share of Hepatocyte Growth Factor by Type in 2016
Table United States Hepatocyte Growth Factor Price (USD/Pcs) by Types (2012-2017)
Figure United States Hepatocyte Growth Factor Sales Growth Rate by Type (2012-2017)
Table United States Hepatocyte Growth Factor Sales (K Pcs) by Application (2012-2017)
Table United States Hepatocyte Growth Factor Sales Market Share by Application (2012-2017)
Figure United States Hepatocyte Growth Factor Sales Market Share by Application (2012-2017)
Figure United States Hepatocyte Growth Factor Sales Market Share by Application in 2016
Table United States Hepatocyte Growth Factor Sales Growth Rate by Application (2012-2017)
Figure United States Hepatocyte Growth Factor Sales Growth Rate by Application (2012-2017)
Table Amgen Inc. Basic Information List
Table Amgen Inc. Hepatocyte Growth Factor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Amgen Inc. Hepatocyte Growth Factor Sales Growth Rate (2012-2017)
Figure Amgen Inc. Hepatocyte Growth Factor Sales Market Share in United States (2012-2017)
Figure Amgen Inc. Hepatocyte Growth Factor Revenue Market Share in United States (2012-2017)
Table AnGes MG, Inc. Basic Information List
Table AnGes MG, Inc. Hepatocyte Growth Factor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure AnGes MG, Inc. Hepatocyte Growth Factor Sales Growth Rate (2012-2017)
Figure AnGes MG, Inc. Hepatocyte Growth Factor Sales Market Share in United States (2012-2017)
Figure AnGes MG, Inc. Hepatocyte Growth Factor Revenue Market Share in United States (2012-2017)
Table Kringle Pharma, Inc. Basic Information List
Table Kringle Pharma, Inc. Hepatocyte Growth Factor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Kringle Pharma, Inc. Hepatocyte Growth Factor Sales Growth Rate (2012-2017)
Figure Kringle Pharma, Inc. Hepatocyte Growth Factor Sales Market Share in United States (2012-2017)
Figure Kringle Pharma, Inc. Hepatocyte Growth Factor Revenue Market Share in United States (2012-2017)
Table M3 Biotechnology, Inc. Basic Information List
Table M3 Biotechnology, Inc. Hepatocyte Growth Factor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure M3 Biotechnology, Inc. Hepatocyte Growth Factor Sales Growth Rate (2012-2017)
Figure M3 Biotechnology, Inc. Hepatocyte Growth Factor Sales Market Share in United States (2012-2017)
Figure M3 Biotechnology, Inc. Hepatocyte Growth Factor Revenue Market Share in United States (2012-2017)
Table Minerva Biotechnologies Corporation Basic Information List
Table Minerva Biotechnologies Corporation Hepatocyte Growth Factor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Minerva Biotechnologies Corporation Hepatocyte Growth Factor Sales Growth Rate (2012-2017)
Figure Minerva Biotechnologies Corporation Hepatocyte Growth Factor Sales Market Share in United States (2012-2017)
Figure Minerva Biotechnologies Corporation Hepatocyte Growth Factor Revenue Market Share in United States (2012-2017)
Table Molecular Partners AG Basic Information List
Table Molecular Partners AG Hepatocyte Growth Factor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Molecular Partners AG Hepatocyte Growth Factor Sales Growth Rate (2012-2017)
Figure Molecular Partners AG Hepatocyte Growth Factor Sales Market Share in United States (2012-2017)
Figure Molecular Partners AG Hepatocyte Growth Factor Revenue Market Share in United States (2012-2017)
Table ViroMed Co., Ltd. Basic Information List
Table ViroMed Co., Ltd. Hepatocyte Growth Factor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure ViroMed Co., Ltd. Hepatocyte Growth Factor Sales Growth Rate (2012-2017)
Figure ViroMed Co., Ltd. Hepatocyte Growth Factor Sales Market Share in United States (2012-2017)
Figure ViroMed Co., Ltd. Hepatocyte Growth Factor Revenue Market Share in United States (2012-2017)
Table Yooyoung Pharmaceutical Co., Ltd. Basic Information List
Table Yooyoung Pharmaceutical Co., Ltd. Hepatocyte Growth Factor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Yooyoung Pharmaceutical Co., Ltd. Hepatocyte Growth Factor Sales Growth Rate (2012-2017)
Figure Yooyoung Pharmaceutical Co., Ltd. Hepatocyte Growth Factor Sales Market Share in United States (2012-2017)
Figure Yooyoung Pharmaceutical Co., Ltd. Hepatocyte Growth Factor Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Hepatocyte Growth Factor
Figure Manufacturing Process Analysis of Hepatocyte Growth Factor
Figure Hepatocyte Growth Factor Industrial Chain Analysis
Table Raw Materials Sources of Hepatocyte Growth Factor Major Players/Suppliers in 2016
Table Major Buyers of Hepatocyte Growth Factor
Table Distributors/Traders List
Figure United States Hepatocyte Growth Factor Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Hepatocyte Growth Factor Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Hepatocyte Growth Factor Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Hepatocyte Growth Factor Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Hepatocyte Growth Factor Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Hepatocyte Growth Factor Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Hepatocyte Growth Factor Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Hepatocyte Growth Factor Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Hepatocyte Growth Factor Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Hepatocyte Growth Factor Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Hepatocyte Growth Factor Sales Volume Share Forecast by Region (2017-2022)
Figure United States Hepatocyte Growth Factor Sales Volume Share Forecast by Region (2017-2022)
Figure United States Hepatocyte Growth Factor Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories